Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development
Gastric carcinoma (GC) is the 2nd most common cause of cancer-related death. Despite advances in conventional treatment and surgical interventions, a high percentage of GC patients still have poor survival. Recently, immunotherapy has become a promising approach to treat GC. Here, we present preclin...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2017-01-01
|
| Series: | BioMed Research International |
| Online Access: | http://dx.doi.org/10.1155/2017/5791262 |